A randomized, 13-week study assessing the efficacy and metabolic effects of paliperidone palmitate injection and olanzapine in first-episode schizophrenia patients
Progress in Neuro-Psychopharmacology and Biological Psychiatry Jan 22, 2018
Huang M, et al. - The efficacy and metabolic effects of paliperidone palmitate (PP) injections against oral olanzapine were assessed in first-episode schizophrenia (FES) patients. In the treatment of FES patients, PP and olanzapine showed similar improvement. Furthermore, findings strengthened the necessity for regular monitoring of metabolic parameters in schizophrenia patients prescribed atypical antipsychotics.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries